bimatoprost, Latisse, Lumigan (cont.)

Pharmacy Author:
Medical and Pharmacy Editor:

PRESCRIPTION: Yes

GENERIC AVAILABLE: No

PREPARATIONS: Solution (eye drops): 0.01% and 0.03%

STORAGE: S Solutions should be store at 2 C to 25 C (36 F to 77 F).

DOSING: The recommended dosage of bimatoprost for reducing IOP is one drop of Lumigan 0.01 or 0.03% in the affected eye(s) once daily in the evening. More frequent administration may reduce the IOP-reducing effect. Reduction in IOP starts approximately four hours after administration and maximum effect occurs in approximately 8 to 12 hours.

The recommended regimen for increasing eyelash growth is one drop of Latisse 0.03% applied with an applicator evenly along the skin of the upper eyelid at the base of the eyelashes of each eye every evening.

DRUG INTERACTIONS:

  • Bimatoprost should be administered at least five minutes before or after other eye medications.
  • Use of bimatoprost for eyelash growth may increase or decrease the effect of prostaglandin-like drugs used for treating elevated IOP.
  • Bimatoprost solution contains benzalkonium chloride, which may be absorbed by soft contact lenses. Contact lenses should be removed prior to application of bimatoprost. Contact lenses may be reinserted 15 minutes following administration of bimatoprost.

PREGNANCY: Use of bimatoprost in pregnancy has not been adequately evaluated.

NURSING MOTHERS: It is not known whether bimatoprost is excreted in human breast milk.

Reference: FDA Prescribing Information


Medically Reviewed by a Doctor on 12/17/2014


Report Problems to the Food and Drug Administration

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Pill Finder Tool

Need help identifying pills and medications?
Use the pill identifier tool on RxList.


Back to Medications Index